Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Hall

Showing results (351-360 of 387) with videos related to

Pageof 39
Sort By:
Plos Biology|August 7, 2018
KDM5 histone demethylases repress immune response via suppression of STINGLizhen Wu, Jian Cao, Wesley L Cai, et al.
Gastroenterology|February 16, 2020
Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in MiceDan Li, Nan Li, Yi-Fan Zhang, et al.
ACS Infectious Diseases|December 21, 2020
The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small MoleculesKirill Gorshkov, Catherine Z Chen, Robert Bostwick, et al.
Journal of the American Society of Nephrology : JASN|April 7, 2025
Characterization of CHK-336, A First-in-Class, Liver-Targeted, Small-Molecule Lactate Dehydrogenase Inhibitor for Hyperoxaluria TreatmentJennifer H Cox, Marc-Olivier Boily, Alexandre Caron, et al.
Nature Reviews. Drug Discovery|January 29, 2022
A call to action for translational sciences in COVID-19 and future pandemicsKanny K Wan, Danielle Davis, Taylor N Lee, et al.
Scientific Reports|October 8, 2017
Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assaysDaniel J Urban, Natalia J Martinez, Mindy I Davis, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2021
Optimization of ether and aniline based inhibitors of lactate dehydrogenasePlamen P Christov, Kwangho Kim, Somnath Jana, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Ampyrone (4-Aminoantipyrine) is a Direct Agonist of Human Tyrosinase and Potential Therapeutic for Oculocutaneous Albinism and Disorders of HypopigmentationMonika B Dolinska, Yuhong Wang, Nathan P Coussens, et al.
JCI Insight|June 18, 2026
Ampyrone is a direct agonist of human tyrosinase and a potential therapeutic for hypopigmentation disordersMonika B Dolinska, Yuhong A Wang, Nathan P Coussens, et al.
Cell Reports|March 14, 2019
Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar AffinityErin R Aho, Jing Wang, Rocco D Gogliotti, et al.
Pageof 39

Showing results (351-360 of 387) with videos related to

Sort By:
Pageof 39
Plos Biology|August 7, 2018
KDM5 histone demethylases repress immune response via suppression of STINGLizhen Wu, Jian Cao, Wesley L Cai, et al.
Gastroenterology|February 16, 2020
Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in MiceDan Li, Nan Li, Yi-Fan Zhang, et al.
ACS Infectious Diseases|December 21, 2020
The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small MoleculesKirill Gorshkov, Catherine Z Chen, Robert Bostwick, et al.
Journal of the American Society of Nephrology : JASN|April 7, 2025
Characterization of CHK-336, A First-in-Class, Liver-Targeted, Small-Molecule Lactate Dehydrogenase Inhibitor for Hyperoxaluria TreatmentJennifer H Cox, Marc-Olivier Boily, Alexandre Caron, et al.
Nature Reviews. Drug Discovery|January 29, 2022
A call to action for translational sciences in COVID-19 and future pandemicsKanny K Wan, Danielle Davis, Taylor N Lee, et al.
Scientific Reports|October 8, 2017
Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assaysDaniel J Urban, Natalia J Martinez, Mindy I Davis, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2021
Optimization of ether and aniline based inhibitors of lactate dehydrogenasePlamen P Christov, Kwangho Kim, Somnath Jana, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Ampyrone (4-Aminoantipyrine) is a Direct Agonist of Human Tyrosinase and Potential Therapeutic for Oculocutaneous Albinism and Disorders of HypopigmentationMonika B Dolinska, Yuhong Wang, Nathan P Coussens, et al.
JCI Insight|June 18, 2026
Ampyrone is a direct agonist of human tyrosinase and a potential therapeutic for hypopigmentation disordersMonika B Dolinska, Yuhong A Wang, Nathan P Coussens, et al.
Cell Reports|March 14, 2019
Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar AffinityErin R Aho, Jing Wang, Rocco D Gogliotti, et al.
Pageof 39